Role of the ALK gene and PI3K/Akt/NF-κB signaling pathway in cervical cancer precancerous lesions
Authors:
Open Access
- 4 September 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1619703
Abstract
Introduction: This study aimed to elucidate the molecular mechanisms underlying cervical precancerous lesions by employing bioinformatic approaches to identify key genes and signaling pathways.Methods: A comprehensive strategy was adopted, beginning with the analysis of GEO datasets to determine differentially expressed genes (DEGs) between cervical squamous intraepithelial lesions (CSILs) and normal cervical tissues. Protein–protein interaction (PPI) networks were constructed using STRING 11.0 and visualized with Cytoscape 3.7.2. Functional annotation through Gene Ontology (GO) and KEGG pathway enrichment using DAVID revealed biological processes, cellular components, molecular functions, and signaling pathways associated with the DEGs. Gene Set Enrichment Analysis (GSEA) further refined critical genes and enriched pathways. Similarly, quantitative real-time PCR (qRT-PCR) was performed on cervical biopsy samples from eligible patients to validate the bioinformatic predictions. Results: The analysis identified 371 common DEGs across datasets, uncovering 102 biological processes, 33 cellular components, 15 molecular functions, 29 significantly enriched pathways, and three key genes. Clinical correlations demonstrated that lesion severity was associated with age, vaginal microbiota composition, and activation of the ALK gene and PI3K/AKT/NF-κB signaling axis. qRT-PCR confirmed increased ALK expression and PI3K/AKT/NF-κB pathway activity in high-grade lesions, supporting their involvement in CSIL pathogenesis. These findings highlight the potential of this research to guide the development of targeted therapies and personalized treatment strategies for cervical precancerous lesions.Discussion: By pinpointing the molecular drivers of disease, this work provides a foundation for interventions aimed at precisely modulating these pathways, improving clinical outcomes and reducing the overall burden of cervical cancer.Keywords
This publication has 40 references indexed in Scilit:
- Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors GroupGynecologic Oncology, 2022
- PRDM4 inhibits cell proliferation and tumorigenesis by inactivating the PI3K/AKT signaling pathway through targeting of PTEN in cervical carcinomaOncogene, 2021
- Author Correction: PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesisNature Communications, 2020
- Class I phosphatidylinositol 3-kinase inhibitors for cancer therapyActa Pharmaceutica Sinica B, 2017
- EEF1A2 inhibiert über eine PI3K/AKT/mTOR-abhängige Stabilisierung von MDM4 die p53-Funktion im LeberzellkarzinomDer Pathologe, 2014
- Up-regulation of eEF1A2 promotes proliferation and inhibits apoptosis in prostate cancerBiochemical and Biophysical Research Communications, 2014
- Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer CellsCell, 2009
- The prognostic significance of elongation factor eEF1A2 in ovarian cancerGynecologic Oncology, 2008
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsNature, 2007
- A novel serine/threonine kinase gene, STK33 , on human chromosome 11p15.3Gene, 2001